49 research outputs found
Entecavir (ETV) demonstrates consistent responses throughout baseline disease and demographic subgroups for the treatment of lamivudine-refractory HBeAg(+) patients with chronic hepatitis B
41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver -- APR 26-30, 2006 -- Vienna, AUSTRIAWOS: 000237328100512European Assoc Study Live